As we expected, RRM2, SLC2A1, DDIT4, and VDAC2 were significantly upregulated transcriptionally and translationally in tumor samples (Figure 9), whereas PEBP1 and IL33 are significantly reduced in tumorous tissues (Figure 9). This evidence concerns the gene SLC2A1 and neoplasm.